# name
Thinner and wiser? Prospects of GLP-1 agonists in psychiatry

# metadata.dc.description.abstract[].value
In recent years, growing scientific attention has converged on the intricate, bidirectional relationship between physical health and mental well-being. Chronic inflammation, disruptions in the gut–brain axis and microbiota, and metabolic alterations such as obesity and type 2 diabetes have all been implicated in the pathophysiology of neuropsychiatric disorders. These insights are not merely academic—they are transforming how we approach, frame, and treat neuropsychiatric disorders.

# metadata.dc.relation.ispartof[].value
European Neuropsychopharmacology, 2025, vol. 97, p. 3-4

# metadata.dc.source[].value
Articles publicats en revistes (Medicina)

# metadata.dc.title[].value
Thinner and wiser? Prospects of GLP-1 agonists in psychiatry